Local Anesthetics

Correct Answer

B — Alpha-1 adrenergic receptor agonist

Rationale

Epinephrine produces vasoconstriction at the injection site by activating alpha-1 adrenergic receptors on vascular smooth muscle. Alpha-1 receptor stimulation causes smooth muscle contraction and narrowing of blood vessels, which reduces local blood flow and slows absorption of the local anesthetic into the systemic circulation. Alpha-2 adrenergic receptors mediate presynaptic inhibition and some central nervous system effects — not the peripheral vasoconstriction relevant to local anesthetic additives. Beta-1 adrenergic receptors mediate increases in heart rate and myocardial contractility. Beta-2 adrenergic receptors mediate smooth muscle relaxation including bronchodilation and vasodilation — the opposite of the vasoconstrictive effect produced at the injection site.

Correct Answer

D — Digital nerve block for a finger laceration

Rationale

Epinephrine is absolutely contraindicated for injection into end-artery regions — anatomical areas where a single artery supplies tissue with no collateral circulation. The fingers, toes, penis, tip of the nose, and ear pinnae are the classic end-artery regions. Vasoconstriction in these areas can reduce blood flow enough to cause ischemia and tissue necrosis. A digital nerve block for a finger laceration involves injection adjacent to the digital arteries in the finger — a classic end-artery location. Epidural anesthesia, femoral nerve block, and abdominal infiltration all involve areas with adequate collateral circulation, where epinephrine addition is standard and safe practice.

Correct Answer

A — Lidocaine

Rationale

Lidocaine is the agent of choice for intravenous regional anesthesia — the technique in which local anesthetic is injected into a venous catheter in an exsanguinated limb isolated by tourniquet, saturating tissue and nerve endings via the venous system. Lidocaine is selected for this technique because it is safe when released into the systemic circulation after tourniquet deflation, provided the minimum inflation time of 20 minutes has been observed to allow tissue fixation. Bupivacaine is absolutely contraindicated for intravenous regional anesthesia because premature or inadvertent tourniquet deflation delivers a bupivacaine bolus intravenously, risking cardiac arrest that is extremely difficult to reverse. Ropivacaine and tetracaine are not used for this technique.

Correct Answer

C — Bupivacaine and ropivacaine

Rationale

Bupivacaine and ropivacaine are the local anesthetics used for low-concentration epidural analgesia — the technique that provides effective pain relief while preserving enough motor function for the patient to ambulate. At dilute concentrations, both agents block the small pain-transmitting fibers while leaving the large motor fibers largely intact, producing effective labor analgesia without motor paralysis. Ropivacaine is particularly valued for its motor-sparing properties. Lidocaine is used for epidural anesthesia but is intermediate-acting and less suited to the prolonged infusions used in labor. Tetracaine is a long-acting ester used for spinal anesthesia, not epidural infusions. Cocaine is a topical-only agent not appropriate for epidural use. Chloroprocaine is short-acting and used for surgical epidural anesthesia requiring rapid onset and recovery. Mepivacaine and prilocaine are not standard agents for labor epidural analgesia.

Correct Answer

B — Epinephrine

Rationale

Epinephrine is included in the test dose injected before the full local anesthetic dose specifically because it serves as a marker of intravascular injection. If the needle tip or catheter is inside a blood vessel rather than the epidural space, the injected epinephrine enters the systemic circulation and produces a rapid rise in heart rate — typically 20 or more beats per minute within 60 seconds. This tachycardia (faster-than-normal heart rate) is the signal that the needle or catheter is intravascular and the injection must be stopped immediately. Lidocaine in the test dose provides the local anesthetic component and can also signal intravascular placement through early central nervous system symptoms, but the heart rate marker from epinephrine is the primary safety signal. Methylene blue is the treatment for methemoglobinemia and has no role in test doses.

Correct Answer

D — A vasoconstrictor additive that prolongs duration and reduces peak systemic absorption of the local anesthetic

Rationale

Epinephrine is classified as a vasoconstrictor additive in local anesthetic solutions — it is not itself a local anesthetic and does not block sodium channels or produce nerve conduction blockade. Its role is to constrict local blood vessels at the injection site, which slows systemic absorption of the local anesthetic, extends the duration of nerve blockade, lowers the peak plasma concentration of the local anesthetic (reducing systemic toxicity risk), and serves as a marker of intravascular injection when a test dose is used. Epinephrine has no direct anesthetic, opioid, or preservative properties. The preservative in multi-dose local anesthetic vials is methylparaben, a structurally distinct compound.

Correct Answer

A — Epinephrine activates alpha-1 adrenergic receptors on vascular smooth muscle, causing vasoconstriction that slows local anesthetic absorption and prolongs drug concentration at the nerve

Rationale

Epinephrine prolongs local anesthetic duration by reducing local blood flow through alpha-1 adrenergic receptor-mediated vasoconstriction of vessels at the injection site. With reduced blood flow, the local anesthetic is absorbed into the systemic circulation more slowly. Drug concentration at the nerve falls more gradually, extending the period during which enough drug is present to maintain blockade. This is a pharmacokinetic effect — epinephrine itself has no sodium channel-blocking or direct anesthetic properties. Option B attributes nerve blockade to epinephrine directly, which is pharmacologically unsupported. Option C invokes a beta-2 mechanism on the nerve membrane that does not exist clinically. Option D proposes a pH effect — while tissue pH does influence local anesthetic ionization, epinephrine does not raise local tissue pH; this is not the mechanism of prolonged duration.

Correct Answer

C — Epinephrine-induced vasoconstriction slows systemic absorption of bupivacaine, reducing the peak plasma concentration that reaches the heart and central nervous system

Rationale

Systemic local anesthetic toxicity is concentration-dependent — it occurs when plasma drug levels rise high enough to block sodium channels in the brain and heart. Epinephrine reduces this risk by constricting blood vessels at the injection site, which slows the rate at which bupivacaine is absorbed into the systemic circulation. The lower absorption rate translates directly to a lower peak plasma concentration. Because the toxic threshold is a plasma concentration, reducing peak levels provides a meaningful safety margin, particularly when large volumes are used for major nerve blocks. Option A describes chemical binding in solution that does not occur — epinephrine and local anesthetics are pharmacologically independent molecules. Option B invokes cardiac redistribution via beta-1 activation, which is not the mechanism by which epinephrine reduces toxicity risk from peripheral injection. Option D attributes a central nervous system protective effect to epinephrine that has no pharmacological basis in this context.

Correct Answer

B — The epinephrine entered a blood vessel rather than the epidural space, reached the systemic circulation, and stimulated cardiac beta-1 adrenergic receptors — indicating intravascular needle placement

Rationale

A rise in heart rate of 20 or more beats per minute within 60 seconds of a test dose containing epinephrine is a positive intravascular test — it indicates that the needle tip or catheter is inside a blood vessel rather than the epidural space. When epinephrine reaches the systemic circulation directly via an intravascular injection, it stimulates beta-1 adrenergic receptors in the heart, producing a rapid increase in heart rate. This is a warning sign that demands immediate cessation of the injection — if the full local anesthetic dose were delivered intravascularly, the resulting plasma concentration could cause seizures and cardiac arrest. Option A invokes a spinal cord mechanism that does not exist for this drug at these doses. Option C attributes the tachycardia to the local anesthetic component — while local anesthetic toxicity can produce cardiovascular effects, the rapid heart rate rise within 60 seconds specifically from a small epinephrine-containing test dose is the epinephrine marker, not a local anesthetic toxicity sign. Option D has the interpretation reversed — tachycardia after a test dose is a warning of intravascular placement, not confirmation of correct epidural placement.

Correct Answer

D — The fingers are supplied by end-arteries with no collateral circulation, so epinephrine-induced vasoconstriction can reduce blood flow enough to cause ischemia and tissue necrosis

Rationale

End-artery regions are anatomical areas supplied by a single arterial pathway with no collateral vessels that could maintain blood flow if the main artery is constricted or occluded. The fingers, toes, penis, tip of the nose, and ear pinnae are the classic end-artery regions. When epinephrine is injected in these locations, alpha-1 adrenergic receptor-mediated vasoconstriction reduces or eliminates blood flow to tissue that has no alternative supply. The resulting ischemia can progress to tissue necrosis. In anatomical regions with collateral circulation — such as the thigh, abdomen, or back — epinephrine-induced vasoconstriction of one vessel is compensated by flow through adjacent vessels, and ischemia does not occur. Option A attributes the danger to nerve sensitivity rather than vascular anatomy, which does not reflect the mechanism. Option B describes a practical inconvenience rather than a safety mechanism. Option C misidentifies systemic absorption rate as the concern — the danger is local tissue ischemia, not systemic epinephrine toxicity.

Correct Answer

A — Lower concentrations selectively block small pain-transmitting fibers while sparing large motor fibers, because smaller fibers require lower drug concentrations to be blocked; higher concentrations block both fiber types

Rationale

The concentration-dependent selectivity of epidural analgesia reflects the differential sensitivity of nerve fibers to local anesthetic blockade. Small, unmyelinated type C fibers and small myelinated type A-delta fibers transmit pain and temperature signals — these are blocked at lower drug concentrations. Large, heavily myelinated type A-alpha motor fibers require higher drug concentrations to be blocked because their widely spaced nodes of Ranvier and thick myelin make them more resistant. At dilute epidural concentrations used for labor analgesia, enough drug reaches small pain fibers to produce effective blockade while remaining below the threshold needed to block large motor fibers — the patient feels no pain but retains motor function. Increasing the concentration for surgical anesthesia raises drug levels above the motor fiber threshold, producing the dense combined sensory and motor block needed for surgery. Option B describes an anatomical model of dorsal versus ventral horn targeting that does not account for the fiber-size-dependent pharmacology observed epidurally. Option C mischaracterizes the block as irreversible at higher concentrations — local anesthetic blockade is always reversible. Option D invokes receptor subtypes that do not exist; bupivacaine acts on the same voltage-gated sodium channel in all fibers.

Correct Answer

C — When the tourniquet is deflated, the drug-containing venous blood in the limb enters the systemic circulation; epinephrine released as a systemic bolus at this point poses an unacceptable cardiovascular risk

Rationale

In intravenous regional anesthesia, local anesthetic is injected into the venous system of an exsanguinated limb isolated by a tourniquet. The drug saturates the limb veins and reaches nerve endings through the venous system. When the tourniquet is deflated at the end of the procedure, the drug-containing venous blood in the limb re-enters the systemic circulation. If epinephrine were included, it would be released simultaneously as a systemic bolus, producing potentially dangerous cardiovascular effects — tachycardia, hypertension, and arrhythmia. The minimum tourniquet inflation time of 20 minutes before deflation is specified partly to allow local anesthetic fixation to nerve tissue, but no such protection applies to epinephrine. Option A inverts the pharmacological effect — epinephrine produces vasoconstriction, not reduced venous distribution that would impair the technique. Option B mischaracterizes tourniquet physiology. Option D describes a chemical incompatibility that does not exist — epinephrine and lidocaine are routinely combined in solution.

Correct Answer

B — Epinephrine slows systemic absorption of lidocaine by constricting local blood vessels, so a larger total dose is needed to reach the same peak plasma concentration that would be toxic

Rationale

Local anesthetic toxicity is determined by peak plasma concentration — the highest drug level achieved in the bloodstream after injection. Epinephrine-induced vasoconstriction slows the rate of lidocaine absorption from the injection site. When absorption is slower, peak plasma concentration is lower for the same total injected dose. Conversely, a larger total dose can be given while still achieving a peak plasma concentration below the toxic threshold. The dose limit effectively increases because the same pharmacokinetic relationship — dose determines peak concentration — now operates with a slower absorption rate. Option A proposes a direct neuroprotective effect of epinephrine that has no pharmacological basis. Option C invokes increased hepatic blood flow and accelerated metabolism — while epinephrine does increase cardiac output, this is not the mechanism that accounts for the higher dose limit. Option D describes protein-binding competition that does not occur between epinephrine and lidocaine to any clinically meaningful degree.

Correct Answer

D — Cocaine simultaneously provides topical anesthesia and vasoconstriction by blocking norepinephrine reuptake at nerve terminals, reducing bleeding without requiring a separate epinephrine additive

Rationale

Cocaine is the only local anesthetic that produces vasoconstriction rather than vasodilation at the site of application. By blocking the norepinephrine reuptake transporter at sympathetic nerve terminals, cocaine causes norepinephrine to accumulate at vascular smooth muscle receptors, producing vasoconstriction. This makes cocaine uniquely valuable for nasal and pharyngeal procedures, where controlling mucosal bleeding is as important as producing anesthesia. Other topical local anesthetics — including lidocaine — cause vasodilation at clinical concentrations and require a separate epinephrine additive when vasoconstriction is needed. Cocaine provides both effects from a single agent. Option A contains a pharmacological error — cocaine's pKa is actually relatively high (8.7), predicting slower onset by pKa-based reasoning, not faster. Option B mischaracterizes cocaine's pharmacokinetic profile — cocaine's systemic absorption from mucosa is rapid, contributing to its abuse potential. Option C is a factual error — lidocaine and tetracaine are also available as topical preparations for mucosal use.

Correct Answer

A — The tachycardia indicates intravascular placement of the epidural needle or catheter; the injection must be stopped immediately and the needle repositioned before any further drug is given

Rationale

A rise in heart rate of 20 or more beats per minute within 60 seconds of a test dose containing epinephrine is the positive intravascular signal. This patient's heart rate rose 24 beats per minute within 45 seconds — a clear positive test. When the needle or catheter tip is intravascular, the injected epinephrine bypasses the epidural space and enters the bloodstream directly, stimulating cardiac beta-1 adrenergic receptors and producing rapid tachycardia. The correct response is to stop the injection immediately, because injecting the full local anesthetic dose into a blood vessel could deliver enough drug to cause seizures or cardiac arrest. The needle or catheter must be repositioned and the test dose repeated before proceeding. Option B has the interpretation reversed — tachycardia after a test dose is a warning, not a confirmation of correct epidural placement. In correct epidural placement, the test dose produces no significant heart rate change because epinephrine absorption from the epidural space is slow and the systemic dose is too small to produce tachycardia within 60 seconds. Option C misattributes the response to labor pain rather than recognizing the pharmacological marker. Option D describes subarachnoid placement, which would produce rapid onset of dense spinal block — a different clinical picture than isolated tachycardia.

Correct Answer

C — At low concentrations, bupivacaine blocks small pain-transmitting fibers while leaving large motor fibers unblocked, because small fibers require lower drug concentrations to be blocked

Rationale

The differential sensitivity of nerve fibers to local anesthetic blockade is the pharmacological basis of the walking epidural. Small, unmyelinated type C fibers and small myelinated type A-delta fibers — which carry pain and temperature signals — are blocked at lower drug concentrations than the large, heavily myelinated type A-alpha motor fibers. When bupivacaine is infused at dilute concentrations, drug levels at the nerve roots are sufficient to block small pain fibers below the threshold needed to produce meaningful blockade of large motor fibers. The result is effective pain relief without motor paralysis. If the concentration is increased — for example, when converting to surgical anesthesia for a cesarean section — the higher drug levels cross the motor fiber threshold and produce dense combined sensory and motor block. Option A invokes receptor subtype selectivity between pain and motor neurons that does not exist — bupivacaine acts on the same voltage-gated sodium channel in all fibers. Option B describes anatomical segregation of sensory and motor roots in the epidural space that is not pharmacologically accurate at the concentration level; drug distribution in the epidural space is not selective enough to account for fiber-type differential blockade by anatomical targeting alone. Option D is a fabrication — dilute bupivacaine epidural produces genuine sodium channel-mediated nerve blockade, not a placebo effect.

Correct Answer

B — Bupivacaine's dose limit is set by its cardiotoxic potential — the plasma concentrations that cause lethal cardiac arrhythmias — so slowing absorption does not raise the ceiling at which catastrophic toxicity occurs

Rationale

For lidocaine, the dose limit is governed primarily by the plasma concentration that produces central nervous system and cardiovascular toxicity — and because epinephrine slows absorption, the same total dose produces a lower peak plasma concentration, effectively raising the amount that can be safely administered. For bupivacaine, the dose limit is set by a different concern: the plasma concentration at which bupivacaine causes cardiac arrhythmias and cardiac arrest that are notoriously resistant to resuscitation. Slowing absorption with epinephrine changes the rate at which bupivacaine reaches the systemic circulation, but it does not change the concentration at which the drug produces lethal cardiac toxicity — nor does it reduce the severity of that toxicity when it occurs. The cardiotoxic ceiling is a property of the drug's pharmacodynamics, not its absorption kinetics. For this reason, the maximum dose of bupivacaine remains approximately 2 to 3 milligrams per kilogram regardless of epinephrine addition, whereas lidocaine's limit rises from approximately 4 to 5 milligrams per kilogram to approximately 7 milligrams per kilogram with epinephrine. Option A overstates the effect of protein binding on absorption — bupivacaine's high protein binding primarily determines duration of action at the nerve, not the rate of systemic absorption. Option C invokes hepatic blood flow changes that are not the mechanism accounting for the dose limit difference between the two agents. Option D is pharmacologically reversed — bupivacaine, like most local anesthetics, causes vasodilation rather than vasoconstriction.

Correct Answer

D — Lidocaine is used without epinephrine; epinephrine is excluded because tourniquet deflation would release it into the systemic circulation, posing an unacceptable cardiovascular risk

Rationale

Intravenous regional anesthesia uses lidocaine as the only acceptable local anesthetic for this technique. Bupivacaine is absolutely contraindicated because premature or unintended tourniquet deflation delivers a bupivacaine bolus directly into the venous circulation, causing cardiac arrest that is extremely difficult to reverse given bupivacaine's tight, slow-dissociating binding to cardiac sodium channels. Epinephrine must not be added because when the tourniquet is deflated at the end of the procedure — releasing the limb's venous blood contents into the systemic circulation — any epinephrine in the solution is simultaneously released as a systemic bolus. This can cause dangerous tachycardia, hypertension, and arrhythmia. Lidocaine, by contrast, can be safely released into the systemic circulation in gradually increasing amounts after the minimum tourniquet inflation time of 20 minutes, because its cardiovascular profile at these doses is manageable. Option A proposes bupivacaine, which is absolutely contraindicated for this technique. Option B proposes ropivacaine, which is not an established agent for intravenous regional anesthesia. Option C proposes adding epinephrine, which is the specific agent that must be excluded for the reason described above.